Moderna stock popped Wednesday after the CDC recommended the company's RSV vaccine for at-risk adults in their 50s.

New research shows that people with worse symptoms of lactose intolerance tended to report more frequent nightmares.

Dr. Aileen Marty, Infectious Disease Specialist and Professor at Florida International University, joins Bob Sirott to talk ...

Moderna is preparing to test Health Secretary Robert F. Kennedy Jr.'s tougher vaccine policies with a combination flu-COVID ...

El boricua Víctor Caratini conectó el tercer grand slam de su carrera, Christian Walker se fue de 4-3 con una impulsada y los Astros de Houston superaron el martes ...

Dr. Jeffrey Kopin, Chief Medical Officer for Northwestern Medicine Lake Forest Hospital, joins John Williams to talk about ...

Moderna's new flu vaccine, based on the same mRNA technology used in its COVID-19 shot, showed promising results in a major ...

Compared to the standard shot, the mRNA vaccine had an overall vaccine efficacy that was 26.6 percent higher, and 27.4 ...

For the 2025-2026 respiratory viral season, Moderna intends to have mResvia available for both FDA-approved patient populations.

The virus has not yet evolved to spread efficiently between people. Excellent vaccine technology exists, but the government ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.